AFP and hepatocellular carcinoma: We then compared the diagnostic ability of the MPM-B with that of AFP in 113 HBV-related HCC patients and found that only 57 patients (50.44%) had AFP levels higher than 20 ng/mL, whereas, 95 patients (84.1%) were positive for HCC using the MPM-B model (Figure 5).